Presentation download: Improving influenza vaccines: enhanced immunogenicity with MF59® adjuvant

  Dr Niranjan Kanesa-thasan, Head of External Collaborations and Special Projects, Novartis Vaccines & Diagnostics, joined us at the World Vaccine Congress in Washington in 2012 to present research into how to improve influenza vaccines through the addition of the MF59® adjuvant. In his presentation, Dr Kanesa-thasan discusses the effects of the adjuvant on immunogenicity and efficacy, its safety profile …

Pandemic and Prepandemic influenza #vaccine development in the Russian Federation

Dr Alexandra Nikiforova, Chief expert in the Department of Clinical Research, Microgen joined us in 2011 at the World Influenza Congress to share her views on Pandemic and Prepandemic influenza vaccine development in the Russian Federation. Dr Alexandra Nikiforova developed her presentations asking 3 key questions about sufficient pandemic vaccine protectiveness: How many immunizations we need to do? What is …